Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2023, Vol. 19 ›› Issue (05): 611 -615. doi: 10.3877/cma.j.issn.1673-5250.2023.05.016

Review

Changes in size of uterine myoma during pregnancy and its association with adverse pregnancy outcomes

Mengling Zhou, Zhiwei Xue, Shu Zhou()   

  1. Department of Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China; Department of Obstetrics, Chengdu Shuangliu District Maternity and Child Health Care Hospital, Chengdu 610299, Sichuan Province, China
    Department of Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2023-06-01 Revised:2023-09-10 Published:2023-10-01
  • Corresponding author: Shu Zhou
  • Supported by:
    National Key Research and Development Project(2018YFC1004603)

Uterine myoma (UM) is the most common benign tumor of the female genital tract, which often occurs in their reproductive age, the cause has not been clarified so far, and its occurrence and development may be related to estrogen and progesterone. Although the levels of estrogen and progesterone produced in the placenta during pregnancy increases with the increase of gestational age, but the volume of UM does not increase with the increase of estrogen and progesterone levels. Other endocrine hormones produced by the body during pregnancy, and amniotic cavity tension, uterine contraction and other factors also affect the blood supply and growth mode of uterine myoma. Pregnancy complicated with UM is a high risk factor for some adverse pregnancy outcomes, such as premature delivery, placental abruption, postpartum hemorrhage etc., and also increases the rate of cesarean delivery. Therefore, this article combines relevant literature at domestic and abroad to analyze the changes of UM during pregnancy and their association with adverse pregnancy outcomes, to improve the clinical understanding of pregnancy with UM and to provide ideas for clinical correct management of pregnancy with UM.

[1]
Sobel M, Hobson S, Chan C. Uterine fibroids in pregnancy[J]. Can Med Assoc J, 2022, 194(22): e775. DOI: 10.1503/cmaj.211530.
[2]
Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids[J]. Int J Gynaecol Obstet, 2020, 149(1): 3-9. DOI: 10.1002/ijgo.13102.
[3]
Wang X, Wang G, Han R, et al. Uterine fibroids increase the risk of preterm birth and other adverse birth events: a systematic review and Meta-analysis[J]. Transl Pediatr, 2022, 11(6): 978-986. DOI: 10.21037/tp-22-215.
[4]
谢幸,孔北华,段涛,等. 妇产科学[M]. 9版. 北京:人民卫生出版社,2018: 303-306.
[5]
Reis FM, Bloise E, Ortiga-Carvalho TM. Hormones and pathogenesis of uterine fibroids[J]. Best Pract Res Clin Obstet Gynaecol, 2016, 34: 13-24. DOI: 10.1016/j.bpobgyn.2015.11.015.
[6]
Landman AJEMC, Don EE, Vissers G, et al. The risk of preterm birth in women with uterine fibroids: a systematic review and Meta-analysis[J]. PLoS One, 2022, 17(6): e0269478. DOI: 10.1371/journal.pone.0269478.
[7]
Pandit U, Singh M, Ranjan R. Assessment of maternal and fetal outcomes in pregnancy complicated by fibroid uterus[J]. Cureus, 2022, 14(2): e22052. DOI: 10.7759/cureus.22052.
[8]
Yang Q, Al-Hendy A. Update on the role and regulatory mechanism of extracellular matrix in the pathogenesis of uterine fibroids[J]. Int J Mol Sci, 2023, 24(6): 5778. DOI: 10.3390/ijms24065778.
[9]
Yang Q, Ciebiera M, Bariani MV, et al. Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment[J]. Endocr Rev, 2022, 43(4): 678-719. DOI: 10.1210/endrev/bnab039.
[10]
Mitro SD, Peddada S, Chen Z, et al. Natural history of fibroids in pregnancy: national Institute of Child Health and Human Development Fetal Growth Studies - Singletons cohort[J]. Fertil Steril, 2022, 118(4): 656-665. DOI: 10.1016/j.fertnstert.2022.06.028.
[11]
Chill HH, Karavani G, Rachmani T, et al. Growth pattern of uterine leiomyoma along pregnancy[J]. BMC Women′s Heath, 2019, 19(1): 1-5. DOI: 10.1186/s12905-019-0803-5.
[12]
Laughlin SK, Herring AH, Savitz DA, et al. Pregnancy-related fibroid reduction[J]. Fertil Steril, 2010, 94(6): 2421-2423. DOI: 10.1016/j.fertnstert.2010.03.035.
[13]
Mesi Edzie EK, Dzefi-Tettey K, Brakohiapa EK, et al. Assessment of the clinical presentations and ultrasonographic features of uterine fibroids in adult africans: a retrospective study[J]. Oman Med J, 2023, 38(1): e459. DOI: 10.5001/omj.2023.36.
[14]
Sarais V, Cermisoni GC, Schimberni M, et al. Human chorionic gonadotrophin as a possible mediator of leiomyoma growth during pregnancy: molecular mechanisms[J]. Int J Mol Sci, 2017, 18(9): 2014. DOI: 10.3390/ijms18092014.
[15]
Delli Carpini G, Verdecchia V, Papiccio M, et al. Comparison of uterine fibroids′ growth pattern during pregnancy according to fetal sex: an observational study[J]. Biol Sex Differ, 2019, 10(1): 53. DOI: 10.1186/s13293-019-0266-2.
[16]
Reis-de-Carvalho C, Lopes J, Henriques A, et al. Management of pregnancy in case of multiple and giant uterine fibroids[J]. BMJ Case Rep, 2020, 13(11): e235572. DOI: 10.1136/bcr-2020-235572.
[17]
薛智方,吴跃芹,王细先,等. 子宫肌瘤患者孕产时并发症、分娩结局及新生儿结局分析[J]. 医学综述2018, 24(22): 4573-4576. DOI: 10.3969/j.issn.1006-2084.2018.22.039.
[18]
Delli Carpini G, Morini S, Papiccio M, et al. The association between childbirth, breastfeeding, and uterine fibroids: an observational study[J]. Sci Rep, 2019, 9(1): 10117. DOI: 10.1038/s41598-019-46513-0.
[19]
Farland LV, Stern JE, Liu CL, et al. Pregnancy outcomes among women with endometriosis and fibroids: registry linkage study in Massachusetts[J]. Am J Obstet Gynecol, 2022, 226(6): 829.e1-829.e14. DOI: 10.1016/j.ajog.2021.12.268.
[20]
Kim HJ, Lee J, Lee HJ. Differential diagnosis of uterine leiomyoma torsion mimicking ovarian torsion in a second trimester of pregnancy: a case report[J]. Int J Women′s Heath, 2022, 14: 1777-1782. DOI: 10.2147/ijwh.s385321.
[21]
Freytag D, Günther V, Maass N, et al. Uterine fibroids and infertility[J]. Diagnostics (Basel), 2021, 11(8): 1455. DOI: 10.3390/diagnostics11081455.
[22]
欧阳彦兰,曾喜群,黄燕婷,等. 妊娠合并子宫肌瘤孕妇先兆流产发生的危险因素[J]. 中国医药科学2021, 11(22): 145-148. DOI: 10.3969/j.issn.2095-0616.2021.22.039.
[23]
Datir SG, Bhake A. Management of uterine fibroids and its complications during pregnancy: a review of literature[J]. Cureus, 2022, 14(11): e31080. DOI: 10.7759/cureus.31080.
[24]
Hartmann KE, Velez Edwards DR, Savitz DA, et al. Prospective cohort study of uterine fibroids and miscarriage risk[J]. Am J Epidemiol, 2017, 186(10): 1140-1148. DOI: 10.1093/aje/kwx062.
[25]
Sundermann AC, Velez Edwards DR, Bray MJ, et al. Leiomyomas in pregnancy and spontaneous abortion: a systematic review and Meta-analysis[J]. Obstet Gynecol, 2017, 130(5): 1065-1072. DOI: 10.1097/AOG.0000000000002313.
[26]
Girault A, Le Ray C, Chapron C, et al. Leiomyomatous uterus and preterm birth: an exposed/unexposed monocentric cohort study[J]. Am J Obstet Gynecol, 2018, 219(4): 410.e1-410.e7. DOI: 10.1016/j.ajog.2018.08.033.
[27]
Ciavattini A, Clemente N, Delli Carpini G, et al. Number and size of uterine fibroids and obstetric outcomes[J]. J Matern Fetal Neonatal Med, 2015, 28(4): 484-488. DOI: 10.3109/14767058.2014.921675.
[28]
Karlsen K, Schiøler Kesmodel U, Mogensen O, et al. Relationship between a uterine fibroid diagnosis and the risk of adverse obstetrical outcomes: a cohort study[J]. BMJ Open, 2020, 10(2): e032104. DOI: 10.1136/bmjopen-2019-032104.
[29]
Zhao R, Wang X, Zou L, et al. Adverse obstetric outcomes in pregnant women with uterine fibroids in China: a multicenter survey involving 112, 403 deliveries[J]. PLoS One, 2017, 12(11): e0187821. DOI: 10.1371/journal.pone.0187821.
[30]
Coutinho LM, Assis WA, Spagnuolo-Souza A, et al. Uterine fibroids and pregnancy: how do they affect each other?[J]. Reprod Sci, 2022, 29(8): 2145-2151. DOI: 10.1007/s43032-021-00656-6.
[31]
Jenabi E, Fereidooni B. The uterine leiomyoma and placenta previa: a Meta-analysis[J]. J Matern Fetal Neonatal Med, 2019, 32(7): 1200-1204. DOI: 10.1080/14767058.2017.1400003.
[32]
王阳,赵岩. 初次妊娠患者发生前置胎盘的影响因素分析[J]. 中国医科大学学报2021, 50(5): 449-452. DOI: 10.12007/j.issn.0258-4646.2021.05.013.
[33]
Jenabi E, Ebrahimzadeh Zagami S. The association between uterine leiomyoma and placenta abruption: a Meta-analysis[J]. J Matern Fetal Neonatal Med, 2017, 30(22): 2742-2746. DOI: 10.1080/14767058.2016.1261401.
[34]
Harada T, Taniguchi F, Harada T. Increased risk of obstetric complications in patients with adenomyosis: a narrative literature review[J]. Reprod Med Biol, 2022, 21(1): e12473. DOI: 10.1002/rmb2.12473.
[35]
Jenabi E, Khazaei S. The effect of uterine leiomyoma on the risk of malpresentation and cesarean: a Meta-analysis[J]. J Matern Fetal Neonatal Med, 2018, 31(1): 87-92. DOI: 10.1080/14767058.2016.1275553.
[36]
王红梅,沈汝冈,杨惠娟,等. 双胎妊娠合并肌壁间子宫肌瘤孕妇剖宫产术时行肌瘤剔除术的安全性分析[J]. 中华妇产科杂志2022, 57(11): 843-849. DOI: 10.3760/cma.j.cn112141-20220721-00472.
[37]
路畅,胡江涛,李金皎,等. 剖宫产分娩中不同类型子宫肌瘤剔除术的临床特征分析[J]. 首都医科大学学报2022, 43(4): 653-657. DOI: 10.3969/j.issn.1006-7795.2022.04.022.
[38]
Lam SJ, Best S, Kumar S. The impact of fibroid characteristics on pregnancy outcome[J]. Am J Obstet Gynecol, 2014, 211(4): 395.e1-395.e5. DOI: 10.1016/j.ajog.2014.03.066.
[39]
路畅,胡江涛,王晓丹,等. 妊娠合并子宫肌瘤产科特征及妊娠结局临床分析[J]. 中国临床医生杂志2022, 50(10): 1221-1225. DOI: 10.3969/j.issn.2095-8552.2020.10.026.
[40]
Mitro SD, Sundaram R, Chen Z, et al. Leiomyomata, neonatal anthropometry, and pregnancy outcomes in singleton pregnancies[J]. Ann Epidemiol, 2023, 80: 43-52. DOI: 10.1016/j.annepidem.2023.02.008.
[41]
张红媛,顾永忠. 妊娠早期巨大子宫肌瘤术后分娩1例并文献复习[J]. 山东大学学报(医学版), 2023, 61(1): 69-73. DOI: 10.6040/j.issn.1671-7554.0.2022.0981.
[1] Qianmei Li, Guannan He, Jing Zhao, Xi Chen, Yuying Tang, Liqiong Ma, Rong Liang, Tao Yuan, Mingxing Li. Placental microvascular flow imaging characteristics and prognosis of early low-risk and high-risk pregnancies[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(07): 726-732.
[2] Jingyu Qian, Mingming Zheng. Interpretation of the Italian guidelines on non-invasive and invasive prenatal diagnosis:executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology(SIGO)[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 486-492.
[3] Shuqin Zhang, Lian Chen. Diagnosis and treatment of postpartum intrauterine retained products of conception[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 493-497.
[4] Xialin Li, Fang He. Risk assessment and early warning system for postpartum hemorrhage[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 498-503.
[5] Yiming Fei, Zhuo Liu, Lijuan Zhang. Current research status of omics analysis in the molecular mechanism of preterm birth[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 504-510.
[6] Ziyang Liu, Jianjian Cui, Yin Zhao. Current research status on obstetric disseminated intravascular coagulation and its scoring system[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 511-518.
[7] Fanying Zeng, Jie Ruan, Xinghui Liu, Guolin He. Current status of perinatal medicine advances under the new reproductive situation and coping strategies in prenatal care[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 519-524.
[8] Xiaofei Li, Hongli Liu, Qiuling Shi, Jing Tian, Li Li, Hongbo Qi, Xin Luo. A prospective randomized controlled study of low intensity focused ultrasound uterine involution treatment for prevention and treatment of postpartum hemorrhage in natural childbirth women[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 534-539.
[9] Rong Huang, Ziyu Liang, Wenjin Qi. Expression and significance of NLRP3 inflammasome in serum of pregnant women with premature rupture of membranes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 540-548.
[10] Xia He, Rong Huang, Wenjin Qi. High-throughput sequencing study on the abundance of placenta and fetal membrane flora in pregnant women with premature rupture of membranes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 549-555.
[11] Jiangyan Xie, Yafei Wang, Fang He. Pregnancy complicated with thrombotic thrombocytopenic purpura:two cases report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 556-563.
[12] Xiaoyan Han, Hua Yang. Relationship between low level of serum placental growth factor in the second trimester pregnancy women and adverse fetal prognosis[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 398-402.
[13] Jiali Du, Rui Bao, Chunhong Qiao, Wei Han. Construction of a prediction model for adverse pregnancy outcomes after emergency cervical cerclage in pregnant women with cervical incompetence during the second trimester[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 403-409.
[14] Jing Zhang, Chang Liu, Chengge Hua. Progress in the treatment of oral diseases during pregnancy[J]. Chinese Journal of Stomatological Research(Electronic Edition), 2024, 18(05): 340-344.
[15] Jingyun Xu, Bo Ding, Yuhui Jiang, Yang Shen. The practice and consideration of single-site laparoscopic operation during pregnancy[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2024, 17(05): 262-266.
Viewed
Full text


Abstract